Anisodamine hydrobromide ameliorates acute lung injury <i>via</i> inhibiting pyroptosis in murine sepsis model-Reference-Cited by-同舟云学术

Anisodamine hydrobromide ameliorates acute lung injury via inhibiting pyroptosis in murine sepsis model

Published:2024-08-26 Issue: Volume: Page:1-10
ISSN:0892-3973
Container-title:Immunopharmacology and Immunotoxicology
language:en
Short-container-title:Immunopharmacology and Immunotoxicology

Author:

Zhang Bihua¹²,Luo Li²,Xiong Shiqiang³,Xiao Yuanyuan²⁴,Zhang Ting⁵,Xiang Tao²

Affiliation:

1. College of Medicine, Southwest Jiaotong University, Chengdu, China

2. Department of Emergency, The Affiliated Hospital of Southwest Jiaotong University, The Third People’s Hospital of Chengdu, Chengdu, China

3. Department of Cardiology, The Affiliated Hospital of Southwest Jiaotong University, The Third People’s Hospital of Chengdu, Chengdu, China

4. Department of Emergency, West China Hospital, Sichuan University, Chengdu, China

5. Center of Obesity and Metabolic Diseases, Department of General Surgery, The Third People’s Hospital of Chengdu, Affiliated Hospital of Southwest Jiaotong University, Chengdu, China

Funder

Chengdu Science and Technology Department

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/08923973.2024.2386331

Reference35 articles.

1. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

2. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study

3. Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations

4. Pulmonary Innate Immune Response Determines the Outcome of Inflammation During Pneumonia and Sepsis-Associated Acute Lung Injury

5. Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007